STOCK TITAN

Savers Value Village (NYSE: SVV) GC trades 55,000 shares via 10b5-1 plan

(Neutral)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Savers Value Village, Inc. General Counsel Richard A. Medway exercised stock options covering 55,000 shares of common stock on August 5 and 7, 2026, at exercise prices of $3.16 and $1.41 per share, and sold 55,000 common shares at per-share prices including $10.98, $11.48, $11.98 and $12.48.

The sales are reported as made pursuant to a Rule 10b5-1 trading plan adopted on March 18, 2026. The exercised options were granted under the company’s 2019 Management Incentive Plan from June 2019 and December 2020 awards that are now fully vested.

Positive

  • None.

Negative

  • None.
Insider Medway Richard A.
Role General Counsel
Sold 55,000 shs ($649K)
Approx. gross sale proceeds $649K
Approx. exercise cost $107K
Approx. pre-tax spread $542K
Type Security Shares Price Value
Exercise Stock Options (Right to Purchase) F2, F5, F4 16,656 $3.16 $53K
Exercise Stock Options (Right to Purchase) F2, F3, F4 23,344 $1.41 $33K
Exercise Stock Options (Right to Purchase) F2, F3, F6 5,000 $1.41 $7K
Exercise Common Stock 16,656 $3.16 $53K
Exercise Common Stock 23,344 $1.41 $33K
Exercise Common Stock 5,000 $1.41 $7K
Sale Common Stock F1 15,000 $11.48 $172K
Sale Common Stock F1 15,000 $11.98 $180K
Sale Common Stock F1 15,000 $12.48 $187K
Exercise Stock Options (Right to Purchase) F2, F3, F4 10,000 $1.41 $14K
Exercise Common Stock 10,000 $1.41 $14K
Sale Common Stock F1 10,000 $10.98 $110K
Holdings After Transaction: Stock Options (Right to Purchase) — 403,426 shares (Direct); Common Stock — 14,440 shares (Direct)
Footnotes (6)
  1. F1. The sale was made pursuant to a 10b5-1 Plan adopted by the reporting person on March 18, 2026.
  2. F2. Options previously granted under the Registrant's 2019 Management Incentive Plan. Each option represents the right to receive upon exercise one share of the Registrant's common stock subject to the applicable vesting and settlement conditions.
  3. F3. The June 12, 2019 stock option grant vested in substantially equal annual installments over five years starting March 28, 2020, and was fully vested on March 28, 2024.
  4. F4. The total outstanding excludes the portion of the original option grant that was solely performance-based, which will be reported separately.
  5. F5. The December 9, 2020 stock option grant vested in substantially equal annual installments over five years starting December 9, 2021 and was fully vested on December 9, 2025.
  6. F6. The total outstanding excludes the portion of the original option grant that was solely time-based, which will be reported separately.
Options exercised 55,000 shares Total underlying common shares from stock option exercises on August 5 and 7, 2026
Shares sold 55,000 shares Total Savers Value Village common shares sold on August 5 and 7, 2026
Option exercise prices $3.16 and $1.41 per share Exercise prices for December 9, 2020 and June 12, 2019 stock option grants
Common stock sale prices $10.98, $11.48, $11.98, $12.48 per share Per-share prices for reported common stock sales on August 5 and 7, 2026
10b5-1 plan adoption date March 18, 2026 Date Medway adopted the Rule 10b5-1 trading plan governing the reported sales
Rule 10b5-1 Plan financial
"The sale was made pursuant to a 10b5-1 Plan adopted by the reporting person"
A Rule 10b5-1 plan is a prearranged, written schedule that lets corporate insiders buy or sell company stock at set times or amounts, even if they later learn material nonpublic information. Think of it like setting an automatic thermostat for trades: it creates a clear record that trades were planned in advance, reducing the risk of insider-trading accusations and helping investors trust that insider transactions are routine rather than based on secret information.
Management Incentive Plan financial
"Options previously granted under the Registrant's 2019 Management Incentive Plan"
A management incentive plan is a structured pay program that rewards company executives and senior managers when they meet specific goals, using cash bonuses, stock awards, or options. It matters to investors because it helps align leaders’ actions with shareholder interests—like tying a coach’s bonus to a team’s wins—while influencing retention, risk-taking and potential share dilution, all of which can affect company performance and stock value.
Stock Options (Right to Purchase) financial
"Security title is listed as Stock Options (Right to Purchase)"
performance-based financial
"excludes the portion of the original option grant that was solely performance-based"
time-based financial
"excludes the portion of the original option grant that was solely time-based"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What insider transactions did Savers Value Village (SVV) report for Richard A. Medway?

Richard A. Medway exercised 55,000 stock options into common stock and sold 55,000 common shares. The transactions occurred on August 5 and 7, 2026, and involved multiple option grants under the 2019 Management Incentive Plan at different exercise and sale prices.

How many Savers Value Village (SVV) stock options did Richard Medway exercise and at what prices?

Medway exercised stock options for 55,000 underlying common shares. The options carried exercise prices of $3.16 and $1.41 per share, reflecting December 9, 2020 and June 12, 2019 grants under Savers Value Village’s 2019 Management Incentive Plan, which were fully vested before exercise.

At what prices did Richard Medway sell Savers Value Village (SVV) common stock?

Medway sold a total of 55,000 Savers Value Village common shares at per-share prices of $10.98, $11.48, $11.98 and $12.48. These sales were reported as sales in open-market or private transactions on August 5 and 7, 2026.

Were Richard Medway’s Savers Value Village (SVV) share sales made under a Rule 10b5-1 plan?

Yes. A footnote states the sales were made pursuant to a Rule 10b5-1 Plan adopted by Medway on March 18, 2026. The filing also checks the Rule 10b5-1 affirmation box, indicating the reported sales followed a pre-established trading plan.

Which stock option grants were involved in Richard Medway’s Savers Value Village (SVV) transactions?

The transactions involve options granted under the 2019 Management Incentive Plan. Footnotes describe a June 12, 2019 grant and a December 9, 2020 grant, both vesting in substantially equal annual installments and fully vested by March 28, 2024 and December 9, 2025 respectively.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Medway Richard A.

(Last)(First)(Middle)
C/O SAVERS VALUE VILLAGE, INC.
11400 SE 6TH, SUITE 125

(Street)
BELLEVUE WASHINGTON 98004

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Savers Value Village, Inc. [ SVV ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
General Counsel
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
08/05/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock08/05/2026M10,000A$1.4124,440D
Common Stock08/05/2026S(1)10,000D$10.9814,440D
Common Stock08/07/2026M16,656A$3.1631,096D
Common Stock08/07/2026M23,344A$1.4154,440D
Common Stock08/07/2026M5,000A$1.4159,440D
Common Stock08/07/2026S(1)15,000D$11.4844,440D
Common Stock08/07/2026S(1)15,000D$11.9829,440D
Common Stock08/07/2026S(1)15,000D$12.4814,440D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Options (Right to Purchase)(2)$1.4108/05/2026M10,000 (3)06/12/2029Common Stock10,000$1.4123,344(4)D
Stock Options (Right to Purchase)(2)$3.1608/07/2026M16,656 (5)12/09/2030Common Stock16,656$3.1687,514(4)D
Stock Options (Right to Purchase)(2)$1.4108/07/2026M23,344 (3)06/12/2029Common Stock23,344$1.410(4)D
Stock Options (Right to Purchase)(2)$1.4108/07/2026M5,000 (3)06/12/2029Common Stock5,000$1.41315,912(6)D
Explanation of Responses:
1. The sale was made pursuant to a 10b5-1 Plan adopted by the reporting person on March 18, 2026.
2. Options previously granted under the Registrant's 2019 Management Incentive Plan. Each option represents the right to receive upon exercise one share of the Registrant's common stock subject to the applicable vesting and settlement conditions.
3. The June 12, 2019 stock option grant vested in substantially equal annual installments over five years starting March 28, 2020, and was fully vested on March 28, 2024.
4. The total outstanding excludes the portion of the original option grant that was solely performance-based, which will be reported separately.
5. The December 9, 2020 stock option grant vested in substantially equal annual installments over five years starting December 9, 2021 and was fully vested on December 9, 2025.
6. The total outstanding excludes the portion of the original option grant that was solely time-based, which will be reported separately.
Remarks:
/s/ Richard Medway08/07/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)